Document is current

Article History

Received: 15 November 2023

Accepted: 30 May 2024

First Online: 10 June 2024

Declarations

:

: The QResearch ethics approval by the East Midlands-Derby Research Ethics Committee [reference 18/EM/0400] and reviewed by the QResearch science committee (Project OX107).

: Consent for publication was obtained from all co-authors.

: JHC reports grants from National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, grants from John Fell Oxford University Press Research Fund, and other research councils, during the conduct of the study. JHC is an unpaid director of QResearch, a not-for-profit organisation which is a partnership between the University of Oxford and EMIS Health who supply the QResearch database used for this work. Until 09 Aug 2023, JHC had a 50% shareholding in ClinRisk Ltd, co-owning it with her husband, who was an executive director. On 9th August 2023, 100% of the share capital was donated to Endeavour Health Care Charitable Trust and the company renamed to Endeavour Predict Ltd. JHC is an unpaid consultant to Endeavour Predict Ltd and her husband is a non-executive director to cover the transition. Endeavour Predict Ltd produces open and closed source software to implement clinical risk algorithms (outside this work) into clinical computer systems. All other authors declare no competing interests.